Project 4: Measuring Chronic Exposure To And Bioavailability Of Organic Chemicals

项目 4:测量有机化学品的长期接触和生物利用度

基本信息

项目摘要

The proposed research addresses the broad SRP theme of Detection Research and more specifically the development of passive samplers for multi-chemical detection and determination of the degree of bioavailability in water and sediment. Aim 1 will develop a universal passive sampling device (PSD) for measuring the time-weighted-average chronic exposure to hundreds of organic chemicals in water. We will advance the theory, design, and application of PSDs to a very broad range of physico-chemical properties (e.g., KOW = 0-9) so that nearly every organic chemical on the Superfund Priority List of Chemicals, and many of their metabolites, will be sampled by a single PSD. We hypothesize that a mixed-polymer sorptive phase contained within a non-selective and highly porous membrane will allow linear uptake of nearly all organic chemicals. Aim 2 will establish the use of PSDs to measure the bioavailable fraction of PCBs and PCB metabolites in water, sediment, and soil. We will conduct laboratory bioavailability experiments with PCB-contaminated soil, sediment and water to advance our understanding of the mechanisms controlling PCB bioavailability and perform field verification at NPL sites. In collaboration with Project 1, we will use extracts of our samples to determine the relationship of our bioavailability measure to the dioxin toxic equivalency factor response in Project 1 cell assays. Aim 3 will establish the use of PSDs to measure the bioavailable fraction of PAHs and PAH metabolites in water, sediment, and soil. In collaboration with Project 5, we will perform studies very similar to those in Aim 2 to develop the use of PSDs to measure PAH and PAH metabolite bioavailability under both controlled laboratory conditions and at NPL sites. This work will advance our understanding of and ability to measure the partitioning of PAHs and metabolites among dissolved organic carbon, soft and hard (soot) particulate carbon, weathered oil/oil product phases, and biota. We hypothesize that our novel PSD design will provide an accurate measure of bioavailable chronic exposure under a broad range of conditions and that PSD-derived data will overcome a critical barrier to more accurate estimates of bioavailability and risk.
拟议的研究涉及检测研究的广泛SRP主题,更具体地说,是开发用于多种化学检测和确定水和沉积物中生物可利用性程度的被动采样器。目标1将开发一种通用被动采样设备(PSD),用于测量水中数百种有机化学品的时间加权平均慢性暴露。我们将把PSD的理论、设计和应用推进到非常广泛的物理化学性质(例如,KOW=0-9),以便几乎所有超级基金优先化学品清单上的有机化学品及其许多代谢物都将由一个PSD进行采样。我们假设,包含在非选择性和高度多孔的膜中的混合聚合物吸附相将允许线性吸收几乎所有的有机化学品。目标2将建立使用PSD来测量水、沉积物和土壤中多氯联苯和多氯联苯代谢物的生物可用分数。我们将利用多氯联苯污染的土壤、沉积物和水进行实验室生物有效性实验,以加深我们对多氯联苯生物有效性控制机制的理解,并在NPL现场进行现场验证。与Project 1合作,我们将使用我们样本的提取物来确定我们的生物利用度指标与Project 1细胞分析中的二恶英毒性当量因子响应之间的关系。目标3将建立使用PSD来测量水、沉积物和土壤中多环芳烃和多环芳烃代谢物的生物可用分数。我们将与项目5合作,进行与目标2非常相似的研究,以开发使用PSD在受控实验室条件下和在NPL地点测量PAH和PAH代谢物的生物利用度。这项工作将 提高我们对多环芳烃和代谢物在溶解有机碳、软和硬(煤烟)颗粒碳、风化石油/石油产品相和生物群之间分配的理解和能力。我们假设,我们新颖的PSD设计将在广泛的条件下提供对生物可用慢性暴露的准确测量,并且PSD派生的数据将克服更准确地估计生物利用度和风险的关键障碍。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JAMES A SWENBERG其他文献

JAMES A SWENBERG的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JAMES A SWENBERG', 18)}}的其他基金

Agilent 6490 LCMS Triple Quadrupole Mass Spectrometer with 1260 Infinity Chip Cub
配备 1260 Infinity Chip Cub 的 Agilent 6490 LCMS 三重四极杆质谱仪
  • 批准号:
    8247540
  • 财政年份:
    2012
  • 资助金额:
    $ 31.53万
  • 项目类别:
ADDUCTS AS QUANTITATIVE MARKERS OF BUTADIENE MUTAGENESIS
加合物作为丁二烯诱变的定量标记
  • 批准号:
    7900708
  • 财政年份:
    2009
  • 资助金额:
    $ 31.53万
  • 项目类别:
UNC-CH CENTER FOR ENVIRONMENTAL HEALTH & SUSCEPTIBILITY
UNC-CH 环境健康中心
  • 批准号:
    7901920
  • 财政年份:
    2009
  • 资助金额:
    $ 31.53万
  • 项目类别:
ENVIRONMENTAL EXPOSURE AND EFFECT OF HAZARDOUS CHEMICALS
危险化学品的环境暴露和影响
  • 批准号:
    7916291
  • 财政年份:
    2009
  • 资助金额:
    $ 31.53万
  • 项目类别:
ENVIRONMENTAL EXPOSURE AND EFFECT OF HAZARDOUS CHEMICALS
危险化学品的环境暴露和影响
  • 批准号:
    7916290
  • 财政年份:
    2009
  • 资助金额:
    $ 31.53万
  • 项目类别:
ENVIRONMENTAL EXPOSURE AND EFFECT OF HAZARDOUS CHEMICALS
危险化学品的环境暴露和影响
  • 批准号:
    7916289
  • 财政年份:
    2009
  • 资助金额:
    $ 31.53万
  • 项目类别:
DNA Adducts as Biomarkers of Exposure and Effect - Biomedical
DNA 加合物作为暴露和效应的生物标志物 - 生物医学
  • 批准号:
    7067245
  • 财政年份:
    2006
  • 资助金额:
    $ 31.53万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    7067255
  • 财政年份:
    2006
  • 资助金额:
    $ 31.53万
  • 项目类别:
LC-MS/MS FOR HIGHLY SENSITIVE BIOMARKER DETECTION
用于高灵敏度生物标志物检测的 LC-MS/MS
  • 批准号:
    6877300
  • 财政年份:
    2005
  • 资助金额:
    $ 31.53万
  • 项目类别:
LC-MS/MS FOR HIGHLY SENSITIVE BIOMARKER DETECTION: CANCER
用于高灵敏度生物标志物检测的 LC-MS/MS:癌症
  • 批准号:
    7166396
  • 财政年份:
    2005
  • 资助金额:
    $ 31.53万
  • 项目类别:

相似海外基金

ASD3MAP: Amorphous Solid Dispersion Digital Design and Manufacturing Platform for rapid and resource-efficient development of bioavailable medicines
ASD3MAP:非晶固体分散体数字设计和制造平台,用于快速、资源高效地开发生物可利用药物
  • 批准号:
    10078996
  • 财政年份:
    2023
  • 资助金额:
    $ 31.53万
  • 项目类别:
    Collaborative R&D
Collaborative Research: Mineral-associated organic matter: an overlooked source and mediator of bioavailable nitrogen
合作研究:矿物相关有机物:被忽视的生物可利用氮的来源和介质
  • 批准号:
    2400998
  • 财政年份:
    2023
  • 资助金额:
    $ 31.53万
  • 项目类别:
    Standard Grant
Preclinical development of highly potent and orally bioavailable PCSK9 inhibitors for patients at high cardiovascular risk
针对高心血管风险患者的高效口服 PCSK9 抑制剂的临床前开发
  • 批准号:
    494266
  • 财政年份:
    2023
  • 资助金额:
    $ 31.53万
  • 项目类别:
    Operating Grants
Optimization of orally bioavailable inhibitors for the treatment of COVID-19 and other human coronavirus infections
用于治疗 COVID-19 和其他人类冠状病毒感染的口服生物可利用抑制剂的优化
  • 批准号:
    10698831
  • 财政年份:
    2023
  • 资助金额:
    $ 31.53万
  • 项目类别:
Investigational New Drug (IND)-enabling and Early-Stage Development of Selective, Reversible, Orally Bioavailable ALDH2 inhibitor ANS-00858 to Treat Alcohol Use Disorder.
用于治疗酒精使用障碍的选择性、可逆、口服生物可利用的 ALDH2 抑制剂 ANS-00858 的研究性新药 (IND) 启用和早期开发。
  • 批准号:
    10748087
  • 财政年份:
    2023
  • 资助金额:
    $ 31.53万
  • 项目类别:
Project 1 – Development of Orally Bioavailable beta-CoV Inhibitors
项目 1 — 口服生物可利用的 β-CoV 抑制剂的开发
  • 批准号:
    10513942
  • 财政年份:
    2022
  • 资助金额:
    $ 31.53万
  • 项目类别:
Making peptides orally bioavailable
使肽具有口服生物利用度
  • 批准号:
    DP220103549
  • 财政年份:
    2022
  • 资助金额:
    $ 31.53万
  • 项目类别:
    Discovery Projects
Collaborative Research: Mineral-associated organic matter: an overlooked source and mediator of bioavailable nitrogen
合作研究:矿物相关有机物:被忽视的生物可利用氮的来源和介质
  • 批准号:
    2103187
  • 财政年份:
    2021
  • 资助金额:
    $ 31.53万
  • 项目类别:
    Standard Grant
Collaborative Research: Mineral-associated organic matter: An overlooked source and mediator of bioavailable nitrogen
合作研究:矿物相关有机物:被忽视的生物可利用氮的来源和介质
  • 批准号:
    2103076
  • 财政年份:
    2021
  • 资助金额:
    $ 31.53万
  • 项目类别:
    Standard Grant
A first-in-class orally bioavailable small molecule dual inhibitor targeting NLRP3 and the dopamine transporter to treat AD
首创的口服生物可利用小分子双重抑制剂,靶向 NLRP3 和多巴胺转运蛋白,用于治疗 AD
  • 批准号:
    10325722
  • 财政年份:
    2021
  • 资助金额:
    $ 31.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了